B-1a cells protect mice from sepsis: Critical role of creb

Journal of Immunology

Volumn 199, Issue 2, 2017, Pages 750-760

  Aziz, Monowar ^a   Holodick, Nichol E ^a   Rothstein, Thomas L ^a   Wang, Ping ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INTERLEUKIN 10; CD19 ANTIGEN; CD19 ANTIGEN, MOUSE; CREB1 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B 1A CELL; B LYMPHOCYTE; BACTERIAL INFECTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMORAL IMMUNITY; INFECTION SENSITIVITY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; SEPSIS; SURVIVAL; ANIMAL; B LYMPHOCYTE SUBPOPULATION; BIOSYNTHESIS; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERLEUKIN-10; MICE; SEPSIS;

EID: 85023196888     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1602056     Document Type: Article

References (48)

1. Aziz, M., A. Jacob, W. L. Yang, A. Matsuda, and P. Wang. 2013. Current trends in inflammatory and immunomodulatory mediators in sepsis. J. Leukoc. Biol. 93: 329-342.
2. Angus, D. C., and T. van der Poll. 2013. Severe sepsis and septic shock. N. Engl. J. Med. 369: 840-851.
3. Hall, M. J., S. N. Williams, C. J. DeFrances, and A. Golosinskiy. 2011. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief 62: 1-8.
4. Seymour, C. W., T. D. Rea, J. M. Kahn, A. J. Walkey, D. M. Yealy, and D. C. Angus. 2012. Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am. J. Respir. Crit. Care Med. 186: 1264-1271.
5. Angus, D. C. 2011. The search for effective therapy for sepsis: back to the drawing board? JAMA 306: 2614-2615.
6. Cinel, I., and S. M. Opal. 2009. Molecular biology of inflammation and sepsis: a primer. Crit. Care Med. 37: 291-304.
7. Rauch, P. J., A. Chudnovskiy, C. S. Robbins, G. F. Weber, M. Etzrodt, I. Hilgendorf, E. Tiglao, J. L. Figueiredo, Y. Iwamoto, I. Theurl, et al. 2012. Innate response activator B cells protect against microbial sepsis. Science 335: 597-601.
8. Kelly-Scumpia, K. M., P. O. Scumpia, J. S. Weinstein, M. J. Delano, A. G. Cuenca, D. C. Nacionales, J. L. Wynn, P. Y. Lee, Y. Kumagai, P. A. Efron, et al. 2011. B cells enhance early innate immune responses during bacterial sepsis. J. Exp. Med. 208: 1673-1682.
9. Aziz, M., N. E. Holodick, T. L. Rothstein, and P. Wang. 2015. The role of B-1 cells in inflammation. Immunol. Res. 63: 153-166.
10. Honda, S., K. Sato, N. Totsuka, S. Fujiyama, M. Fujimoto, K. Miyake, C. Nakahashi-Oda, S. Tahara-Hanaoka, K. Shibuya, and A. Shibuya. 2016. Marginal zone B cells exacerbate endotoxic shock via interleukin-6 secretion induced by Fca/mR-coupled TLR4 signalling. Nat. Commun. 7: 11498.
11. Kantor, A. B., A. M. Stall, S. Adams, L. A. Herzenberg, and L. A. Herzenberg. 1992. Differential development of progenitor activity for three B-cell lineages. Proc. Natl. Acad. Sci. USA 89: 3320-3324.
12. Kantor, A. B., and L. A. Herzenberg. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11: 501-538.
13. Rothstein, T. L., L. A. Herzenberg, N. E. Holodick, and E. Ghosn. 2015. B-1 cell development and function. Ann. N. Y. Acad. Sci. 1362: v-vi.
14. Holodick, N. E., and T. L. Rothstein. 2013. Atypical response of B-1 cells to BCR ligation: a speculative model. Front. Immunol. 4: 457.
15. Haas, K. M., J. C. Poe, D. A. Steeber, and T. F. Tedder. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23: 7-18.
16. Grönwall, C., J. Vas, and G. J. Silverman. 2012. Protective roles of natural IgM antibodies. Front. Immunol. 3: 66.
17. Zhang, X. 2013. Regulatory functions of innate-like B cells. Cell. Mol. Immunol. 10: 113-121.
18. O'Garra, A., and M. Howard. 1992. IL-10 production by CD5 B cells. Ann. N. Y. Acad. Sci. 651: 182-199.
19. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
20. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710.
21. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
22. Yanaba, K., A. Yoshizaki, Y. Asano, T. Kadono, T. F. Tedder, and S. Sato. 2011. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178: 735-743.
23. Weber, G. F., B. G. Chousterman, S. He, A.M. Fenn, M. Nairz, A. Anzai, T. Brenner, F. Uhle, Y. Iwamoto, C. S. Robbins, et al. 2015. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science 347: 1260-1265.
24. Aziz, M., W. L. Yang, S. Matsuo, A. Sharma, M. Zhou, and P. Wang. 2014. Upregulation of GRAIL is associated with impaired CD4 T cell proliferation in sepsis. J. Immunol. 192: 2305-2314.
25. Aziz, M., A. Matsuda, W. L. Yang, A. Jacob, and P. Wang. 2012. Milk fat globule-epidermal growth factor-factor 8 attenuates neutrophil infiltration in acute lung injury via modulation of CXCR2. J. Immunol. 189: 393-402.
26. Holodick, N. E., T. Vizconde, and T. L. Rothstein. 2014. Splenic B-1a cells expressing CD138 spontaneously secrete large amounts of immunoglobulin in nave mice. Front. Immunol. 5: 129.
27. Choi, Y. S., J. A. Dieter, K. Rothaeusler, Z. Luo, and N. Baumgarth. 2012. B-1 cells in the bone marrow are a significant source of natural IgM. Eur. J. Immunol. 42: 120-129.
28. Hotchkiss, R. S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13: 862-874.
29. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
30. Schmitt, E. G., D. Haribhai, J. B. Williams, P. Aggarwal, S. Jia, L. M. Charbonnier, K. Yan, R. Lorier, A. Turner, J. Ziegelbauer, et al. 2012. IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. J. Immunol. 189: 5638-5648.
31. Avni, D., O. Ernst, A. Philosoph, and T. Zor. 2010. Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol. Immunol. 47: 1396-1403.
32. Sanin, D. E., C. T. Prendergast, and A. P. Mountford. 2015. IL-10 production in macrophages is regulated by a TLR-driven CREB-mediated mechanism that is linked to genes involved in cell metabolism. J. Immunol. 195: 1218-1232.
33. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
34. King, E. G., G. J. Bauzá, J. R. Mella, and D. G. Remick. 2014. Pathophysiologic mechanisms in septic shock. Lab. Invest. 94: 4-12.
35. Kim, K. D., J. Zhao, S. Auh, X. Yang, P. Du, H. Tang, and Y. X. Fu. 2007. Adaptive immune cells temper initial innate responses. Nat. Med. 13: 1248-1252.
36. Guimaraẽs-Cunha, C. F., A. M. Alvares-Saraiva, J. de Souza Apostolico, and A. F. Popi. 2016. Radiation-resistant B-1 cells: a possible initiating cells of neoplastic transformation. Immunobiology 221: 845-852.
37. Ha, S. A., M. Tsuji, K. Suzuki, B. Meek, N. Yasuda, T. Kaisho, and S. Fagarasan. 2006. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203: 2541-2550.
38. Savitsky, D., and K. Calame. 2006. B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J. Exp. Med. 203: 2305-2314.
39. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381-2386.
40. Giamarellos-Bourboulis, E. J., E. Apostolidou, M. Lada, I. Perdios, N. K. Gatselis, I. Tsangaris, M. Georgitsi, M. Bristianou, T. Kanni, K. Sereti, et al; Hellenic Sepsis Study Group. 2013. Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome. Crit. Care 17: R247.
41. Tugrul, S., P. E. Ozcan, O. Akinci, Y. Seyhun, A. Cagatay, N. Cakar, and F. Esen. 2002. The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]. Crit. Care 6: 357-362.
42. Medzhitov, R., and T. Horng. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9: 692-703.
43. Wen, A. Y., K. M. Sakamoto, and L. S. Miller. 2010. The role of the transcription factor CREB in immune function. J. Immunol. 185: 6413-6419.
44. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181.
45. Zhang, X., D. T. Odom, S. H. Koo, M. D. Conkright, G. Canettieri, J. Best, H. Chen, R. Jenner, E. Herbolsheimer, E. Jacobsen, et al. 2005. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. USA 102: 4459-4464.
46. Zhou, F., Z. Peng, R. Murugan, and J. A. Kellum. 2013. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit. Care Med. 41: 2209-2220.
47. Latifi, S. Q., M. A. O'Riordan, and A. D. Levine. 2002. Interleukin-10 controls the onset of irreversible septic shock. Infect. Immun. 70: 4441-4446.
48. Griffin, D. O., N. E. Holodick, and T. L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+CD43+CD702. [Published errata appear in 2011 J. Exp. Med. 208: 409; 2011 and J. Exp. Med. 208: 871.] J. Exp. Med. 208: 67-80.